Credit Suisse’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $48.1M | Sell |
367,304
-11,088
| -3% | -$1.39M | 0.05% | 382 |
|
|
2023
Q4 | $46.1M | Sell |
378,392
-20,207
| -5% | -$2.25M | 0.04% | 418 |
|
|
2023
Q3 | $44.7M | Sell |
398,599
-6,920
| -2% | -$879K | 0.05% | 410 |
|
|
2023
Q2 | $59M | Buy |
405,519
+163,501
| +68% | +$22.2M | 0.06% | 342 |
|
|
2023
Q1 | $31.3M | Buy |
242,018
+5,596
| +2% | +$703K | 0.03% | 546 |
|
|
2022
Q4 | $30.1M | Buy |
236,422
+9,495
| +4% | +$1.1M | 0.03% | 556 |
|
|
2022
Q3 | $23.7M | Sell |
226,927
-1,009
| -0.4% | -$111K | 0.03% | 609 |
|
|
2022
Q2 | $23.9M | Buy |
227,936
+3,280
| +1% | +$389K | 0.02% | 636 |
|
|
2022
Q1 | $28.7M | Buy |
224,656
+14,403
| +7% | +$1.74M | 0.02% | 636 |
|
|
2021
Q4 | $25.9M | Buy |
210,253
+4,331
| +2% | +$567K | 0.01% | 968 |
|
|
2021
Q3 | $29.3M | Buy |
205,922
+2,287
| +1% | +$336K | 0.02% | 897 |
|
|
2021
Q2 | $31.9M | Sell |
203,635
-33,212
| -14% | -$5.38M | 0.02% | 906 |
|
|
2021
Q1 | $36.8M | Sell |
236,847
-6,145
| -3% | -$952K | 0.02% | 845 |
|
|
2020
Q4 | $36.4M | Buy |
242,992
+2,288
| +1% | +$323K | 0.02% | 849 |
|
|
2020
Q3 | $31.8M | Sell |
240,704
-78,075
| -24% | -$10.2M | 0.02% | 802 |
|
|
2020
Q2 | $36.9M | Sell |
318,779
-25,644
| -7% | -$2.95M | 0.03% | 666 |
|
|
2020
Q1 | $33.8M | Buy |
344,423
+19,850
| +6% | +$2.6M | 0.03% | 578 |
|
|
2019
Q4 | $47.2M | Buy |
324,573
+63,958
| +25% | +$8.83M | 0.03% | 583 |
|
|
2019
Q3 | $34.7M | Buy |
260,615
+51,341
| +25% | +$6.63M | 0.03% | 626 |
|
|
2019
Q2 | $23.9M | Sell |
209,274
-9,462
| -4% | -$1.11M | 0.02% | 827 |
|
|
2019
Q1 | $27.1M | Sell |
218,736
-16,307
| -7% | -$1.85M | 0.02% | 700 |
|
|
2018
Q4 | $23.7M | Sell |
235,043
-41,963
| -15% | -$4.72M | 0.02% | 708 |
|
|
2018
Q3 | $35.4M | Buy |
277,006
+20,661
| +8% | +$2.46M | 0.03% | 572 |
|
|
2018
Q2 | $27.7M | Sell |
256,345
-40,478
| -14% | -$4.41M | 0.03% | 666 |
|
|
2018
Q1 | $31.4M | Buy |
296,823
+33,450
| +13% | +$3.88M | 0.03% | 615 |
|
|
2017
Q4 | $30.9M | Buy |
263,373
+22,940
| +10% | +$2.59M | 0.03% | 640 |
|
|
2017
Q3 | $27.3M | Sell |
240,433
-64,942
| -21% | -$7.5M | 0.03% | 668 |
|
|
2017
Q2 | $38.1M | Sell |
305,375
-101,966
| -25% | -$12.1M | 0.04% | 509 |
|
|
2017
Q1 | $48.3M | Sell |
407,341
-45,697
| -10% | -$5.18M | 0.04% | 441 |
|
|
2016
Q4 | $45.4M | Buy |
453,038
+59,755
| +15% | +$6.4M | 0.05% | 450 |
|
|
2016
Q3 | $49.6M | Buy |
393,283
+116,589
| +42% | +$14.4M | 0.05% | 431 |
|
|
2016
Q2 | $32.3M | Sell |
276,694
-9,540
| -3% | -$1.08M | 0.04% | 554 |
|
|
2016
Q1 | $29.6M | Buy |
286,234
+4,727
| +2% | +$457K | 0.04% | 549 |
|
|
2015
Q4 | $28M | Sell |
281,507
-62,642
| -18% | -$6.13M | 0.03% | 617 |
|
|
2015
Q3 | $31.4M | Sell |
344,149
-11,873
| -3% | -$1.19M | 0.04% | 544 |
|
|
2015
Q2 | $37.8M | Buy |
356,022
+92,663
| +35% | +$10.3M | 0.04% | 542 |
|
|
2015
Q1 | $30M | Sell |
263,359
-152,286
| -37% | -$17.4M | 0.03% | 634 |
|
|
2014
Q4 | $45.8M | Sell |
415,645
-240,953
| -37% | -$25.4M | 0.04% | 503 |
|
|
2014
Q3 | $64.1M | Sell |
656,598
-922,507
| -58% | -$90.7M | 0.05% | 390 |
|
|
2014
Q2 | $159M | Buy |
1,579,105
+1,303,832
| +474% | +$127M | 0.13% | 148 |
|
|
2014
Q1 | $25.3M | Buy |
275,273
+15,354
| +6% | +$1.42M | 0.02% | 718 |
|
|
2013
Q4 | $23.5M | Buy |
259,919
+48,461
| +23% | +$4.19M | 0.02% | 745 |
|
|
2013
Q3 | $16.9M | Sell |
211,458
-170,403
| -45% | -$13.4M | 0.02% | 836 |
|
|
2013
Q2 | $27.8M | Buy |
+381,861
| New | +$28.6M | 0.03% | 608 |
|
Other funds holding ZBH
Credit Suisse's ZBH Position: Q1 2024 in Review
Credit Suisse reduced its Zimmer Biomet (ZBH) stake by 2.9% in Q1 2024, selling an estimated $1.39M and leaving 367,304 shares worth $48.1M. The position accounts for 0.05% of the portfolio, ranked #382.
Credit Suisse first reported a position in ZBH in Q2 2013 and has held it in 44 quarters since. The position peaked at $159M in Q2 2014. 1,011 funds tracked by Wall St. Rank hold ZBH as of Q1 2024.
- Credit Suisse held 367,304 shares of Zimmer Biomet worth $48.1M as of Q1 2024.
- Credit Suisse sold 11,088 Zimmer Biomet shares in Q1 2024, an estimated $1.39M.
- Zimmer Biomet made up 0.05% of Credit Suisse's portfolio in Q1 2024, its #382 holding.
- Credit Suisse first reported a position in Zimmer Biomet in Q2 2013 and has held it in 44 quarters since.
- Credit Suisse's Zimmer Biomet position peaked at $159M in Q2 2014.
- 1,011 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.